Search

everythinglearnresearchcommunity

for

Search:↓

Selective breeding can enhance immunity in dairy cattle.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Acne is a temporary skin imbalance during puberty that often resolves on its own.

Heat treatment increases hair loss in certain mice.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.